IRCCS Istituto Scientifico Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" - IRST

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Antiphospholipid syndrome1 trial
• Dermatomyositis and polymyositis (myositis)1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Immune thrombocytopenia (ITP)1 trial

Phase

• Phase 11 trial
• Phase 1/21 trial

Status

• Active, not recruiting1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Chugai Pharmaceutical1 trial
• Genmab1 trial

Running trials

• Enrolling by invitation

  Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

  NCT06723106· Phase 1· Chugai Pharmaceutical· Source

• Active, not recruiting

  Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)

  NCT04663347· Phase 1/2· Genmab· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Antiphospholipid syndrome1 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting